X
19
Sandoz B2B, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for A global leader in antibiotics.
One of their notable products is ADALIMUMAB-ADAZ, with a corresponding application number 761071 and regulatory information .
proudly manufactured in the
Sandoz B2B's HYRIMOZ INJECTABLE;INJECTION, medication with 40MG/0.8ML of ADALIMUMAB-ADAZ.